Below is an educational, technical answer to a question many patients and clinicians ask. Percutaneous tumor ablation is a group of minimally invasive techniques in which energy is delivered through a needle-like applicator, placed through the skin under imaging guidance, to destroy a focal tumor in situ. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Percutaneous Tumor Ablation
Intracavitary hypothermia describes controlled temperature therapy delivered directly into a body cavity such as the bladder, and is generally positioned as an adjunct intended to enhance the penetration of intravesical chemotherapy. RFA has an extensive track record in hepatocellular carcinoma (HCC), MWA is frequently applied to liver and lung tumors, and cryoablation is often described for renal cell carcinoma, though indications are always defined by the treating team. Percutaneous tumor ablation is a group of minimally invasive techniques in which energy is delivered through a needle-like applicator, placed through the skin under imaging guidance, to destroy a focal tumor in situ.
What are the side effects of microwave ablation?
Reported side effects of thermal ablation can include a self-limited post-ablation syndrome with low-grade fever and discomfort, as well as localized pain at the applicator site. Less common risks described in the literature include bleeding, injury to adjacent structures, and, for lung ablation, pneumothorax, among others detailed in device documentation. Careful applicator placement under image guidance and appropriate patient selection are intended to limit such risks. The full risk profile depends on the tumor location and the individual, and should be reviewed with the treating physician; this content is educational only.
What This Means in Practice
Manufacturer descriptions of INVAMED platforms reflect intended design and applications rather than guaranteed individual outcomes. Achieving an adequate ablation margin is widely emphasized in the literature for durable local tumor control, and may call for overlapping applications in larger lesions. Image guidance with ultrasound, CT, or other modalities supports accurate applicator placement and monitoring of the treatment zone.
Key Considerations
- Image guidance with ultrasound, CT, or other modalities supports accurate applicator placement and monitoring of the treatment zone.
- Manufacturer descriptions of INVAMED platforms reflect intended design and applications rather than guaranteed individual outcomes.
- Achieving an adequate ablation margin is widely emphasized in the literature for durable local tumor control, and may call for overlapping applications in larger lesions.
Frequently Asked Questions
What determines the ablation zone size?
Published sources note that factors such as generator power, applicator design, application time, and local blood flow influence the ablation zone, and settings are selected by the treating physician.
Who decides whether ablation is appropriate?
A qualified clinical team decides based on tumor characteristics and patient factors; this article is educational and not a treatment recommendation.
Is the HyperTiss set an ablation device?
INVAMED describes HyperTiss as an intracavitary (intravesical) temperature-therapy set intended for adjunctive use with intravesical chemotherapy in bladder cancer, rather than as a standalone tumor ablation device.
About INVAMED
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Clinical and Technical Context
All INVAMED ablation devices are intended for use by trained clinicians under appropriate image guidance and in accordance with the IFU. For lesions near large vessels, the heat-sink effect can influence the completeness of heat-based ablation and is factored into planning. Antenna gauge, active-tip length, and generator power (measured in watts) are the primary variables a clinician balances against the intended ablation zone size for a given lesion. Because ablation is a local therapy, tumor size, number, location relative to vessels and organs, and overall clinical status all influence whether it is appropriate, as determined by a multidisciplinary clinician team.
Related on INVAMED
- Oncology Ablation — product category
- Cryoablation for Renal Tumors: Technology, Uses and Considerations
- How long is recovery after tumor ablation?
- Ablation or Surgical resection? A Technical Comparison
Important Disclaimer
This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.